Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P170018/S023

LIFEPAK CR2 Automated External Defibrillator

Physio-Control, Inc. · Decision date Nov 6, 2025

FDA DECISIONP170018/S023

What did the FDA approve?

FDA records P170018/S023 as a supplement to PMA P170018, with the supplement type “Real-Time Process”. The recorded decision is approval, dated Nov 6, 2025.

FDA approval order statement

approval for minor design changes to the LIFEPAK CR2 (LPCR2) QUIK-STEP Pacing/ECG/Defibrillation electrodes.
Regulatory pathway
PMA supplement
Supplement type
Real-Time Process
Clinical specialty
Cardiovascular
Decision date
Nov 6, 2025
FDA change category
Change Design/Components/Specifications/Material

FDA source record

Regulatory record facts

Identifier
P170018/S023
Regulatory pathway
PMA supplement
Product code
MKJ
Decision code
APPR
Decision date
Nov 6, 2025
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Automated external defibrillators (non-wearable).

Product code
MKJ
FDA device class
3

Review the original FDA PMA listing for the original approval scope and linked supplements.

FDA decision timeline

  1. P170018/S023 received

    Application receipt date recorded by FDA.

  2. P170018/S024 · Related supplement

    LIFEPACK CR2 Automated External Defibrillator (AED)

  3. P170018/S023 · FDA decision

    Real-Time Process

  4. P170018/S025 · Related supplement

    LIFEPAK CR2 Defibrillator

Timeline entries are records held by MedtechLedger for P170018. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P170018

Product / regulatory recordCompanyPathwayDecision dateSource
Physio-Control, Inc.PMA supplementSep 29, 2025FDA
Physio-Control, Inc.PMA supplementJul 30, 2026FDA

Explore the linked device profile

Other records with product code MKJ

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

FDA describes the real-time supplement process as a review route for minor changes to a device, including certain design, software, sterilization or labeling changes.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Physio-Control, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
11811 Willows Rd. NE, Redmond, WA, 98052

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records